Capital Com MENA Securities Trading LLC is regulated by the Capital Market Authority.
Open platformOpen platform

ResMed Publishes Q1 FY2027 Earnings Call Transcript

By Public Technologies
  • ResMed's Oct. 29, 2026, Q1 fiscal 2027 earnings call featured CEO Michael J. Farrell, CFO Aaron Bloomer and investor-relations chief Sallilyn Schwartz.
  • Quarterly revenue reached $1.4 billion; non-GAAP diluted earnings per share rose 14% to $2.91.
  • Management maintained full-year revenue guidance of $5.75 billion-$5.85 billion; non-GAAP earnings per share remain projected at $12-$12.25.
  • Core constant-currency revenue growth guidance remains 5%-7%, with Bloomer calling the midpoint most likely as France's fleet-renewal benefit fades.
  • Non-GAAP gross margin reached 62.5%; deferred Indiana expansion costs create an expected 30-basis-point sequential headwind in Q2.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ResMed Inc. published the original content used to generate this news brief on October 30, 2026, and is solely responsible for the information contained therein.

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.

The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.

To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.